Characterizing MHC-I Genotype Predictive Power for Oncogenic Mutation Probability in Cancer Patients.

Abstract excerpt

MHC class I proteins present intracellular peptides on the cell's surface, enabling the immune system to recognize tumor-specific neoantigens of early neoplastic cells and eliminate them before the tumor develops further. However, variability in peptide-MHC-I affinity results in variable presentation of oncogenic peptides, leading to variable likelihood of immune evasion across both individuals and mutations....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Databases, Genetic
• Share to Exome Sequencing